Kommentar zu „Hypopharynxkarzinom: Lymphknotenmetastasen verringern Überlebenschance“.
[No authors listed]
Laryngorhinootologie. 2024 Jun;103(6):396-397. doi: 10.1055/a-2263-3537. Epub 2024 Jun 3.
Imaging of the larynx and hypopharynx.
Becker M, Burkhardt K, Dulguerov P, Allal A.
Eur J Radiol. 2008 Jun;66(3):460-79. doi: 10.1016/j.ejrad.2008.03.027. Epub 2008 May 20.
Hypopharyngeal cancer.
Wycliffe ND, Grover RS, Kim PD, Simental A Jr.
Top Magn Reson Imaging. 2007 Aug;18(4):243-58. doi: 10.1097/RMR.0b013e3181570c3f.
Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial.
Gong H, Tian S, Ding H, Tao L, Wang L, Wang J, Wang T, Yuan X, Heng Y, Zhang M, Shi Y, Xu C, Wu C, Wang S, Zhou L.
Nat Commun. 2024 Jun 19;15(1):5251. doi: 10.1038/s41467-024-49121-3.
Clinical and Radiological Evaluation of Hypopharyngeal Carcinoma.
Piazza C, Paderno A, Ravanelli M, Pessina C.
Adv Otorhinolaryngol. 2019;83:35-46. doi: 10.1159/000492306. Epub 2019 Feb 12.
[Radiotherapy of hypopharynx cancers].
Pointreau Y, Lafond C, Trémolières P, Legouté F, Servagi-Vernat S, Giraud P, Maingon P, Calais G, Lapeyre M.
Cancer Radiother. 2016 Sep;20 Suppl:S126-30. doi: 10.1016/j.canrad.2016.07.020. Epub 2016 Aug 10.
Hypopharynxkarzinom: Lymphknotenmetastasen verringern Überlebenschance.
[No authors listed]
Laryngorhinootologie. 2024 Jun;103(6):396. doi: 10.1055/a-2263-3513. Epub 2024 Jun 3.
Carcinoma of the hypopharynx.
Gourin CG, Terris DJ.
Surg Oncol Clin N Am. 2004 Jan;13(1):81-98. doi: 10.1016/S1055-3207(03)00122-4.
Current management strategy of hypopharyngeal carcinoma.
Chan JY, Wei WI.
Auris Nasus Larynx. 2013 Feb;40(1):2-6. doi: 10.1016/j.anl.2011.11.009. Epub 2012 Jun 17.
[Squamous cell carcinoma of the hypopharynx and larynx: evidence-based care].
Fayette J, Pointreau Y, Bourhis J, Lefebvre JL.
Bull Cancer. 2014 May 1;101(5):438-44. doi: 10.1684/bdc.2014.1945.
